Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Tomasz Pielak"'
Autor:
Rafał Wójcicki, Tomasz Pielak, Piotr Marcin Walus, Łukasz Jaworski, Bartłomiej Małkowski, Przemysław Jasiewicz, Maciej Gagat, Łukasz Łapaj, Jan Zabrzyński
Publikováno v:
Medicina, Vol 60, Iss 3, p 455 (2024)
Background and Objectives: The objective of this retrospective study was to investigate the association between acetabulum fractures; the mechanism of injury; and variables such as BMI, duration of hospital stay, blood loss, and surgery time. By expl
Externí odkaz:
https://doaj.org/article/33d858032110460182fac1fa6fca6fdd
Autor:
Łukasz Paczesny, Matthias Lorkowski, Tomasz Pielak, Rafał Wójcicki, Gazi Huri, Jan Zabrzyński
Publikováno v:
Applied Sciences, Vol 13, Iss 19, p 10900 (2023)
In this article, the authors review the role of ultrasound guidance in MSK mini-invasive surgery. Ultrasound imaging has become an important tool in the field of musculoskeletal examination and has advantages over the X-ray guidance traditionally use
Externí odkaz:
https://doaj.org/article/5a22d0d26228498d9ebaee86db83bc8e
Autor:
Tomasz Pielak, Rafał Wójcicki, Piotr Walus, Adam Jabłoński, Michał Wiciński, Przemysław Jasiewicz, Bartłomiej Małkowski, Szymon Nowak, Jan Zabrzyński
Publikováno v:
Applied Sciences, Vol 13, Iss 18, p 10546 (2023)
Objective: The objective of this study was to investigate the association between BMI, days spent in hospital, blood loss, and surgery time in patients who suffered from isolated pelvic fractures and pelvic fractures with concomitant injuries (polytr
Externí odkaz:
https://doaj.org/article/4e012f1facd842f38247c7db05145744
Publikováno v:
Endocrine Connections, Vol 8, Iss 6, Pp 772-779 (2019)
Growth hormone deficiency (GHD) syndrome is associated with adverse levels of several risk factors for cardiovascular diseases (CVD), including metabolic inflammation. However, the impact of GHD and GH treatment on low-grade inflammation is unknown.
Externí odkaz:
https://doaj.org/article/f7a39bd2a3c94361b567fec5ae6ba59f
Autor:
Jan Zabrzyński, Łukasz Paczesny, Agnieszka Zabrzyńska, Gazi Huri, Kamil Graboń, Tomasz Pielak, Jacek Kruczyński, Łukasz Łapaj
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 23; Pages: 16127
Complete loss of the meniscus inevitably leads to knee joint degeneration. Smoking is an important factor predicting poor outcome in orthopedics; however, data about its role in meniscus surgery are inconclusive. Smoking could be an important negativ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6162f86c2bbc6b76e114b7c8ac18b340
https://doi.org/10.3390/ijerph192316127
https://doi.org/10.3390/ijerph192316127
Publikováno v:
Endocrine Connections, Vol 8, Iss 6, Pp 772-779 (2019)
Endocrine Connections
Endocrine Connections
Growth hormone deficiency (GHD) syndrome is associated with adverse levels of several risk factors for cardiovascular diseases (CVD), including metabolic inflammation. However, the impact of GHD and GH treatment on low-grade inflammation is unknown.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::309bcad2c5c80ade2bdd0124fafe3fda
https://doi.org/10.1530/ec-19-0159
https://doi.org/10.1530/ec-19-0159
Autor:
Andreas Kristian Pedersen, Thor Aage Skovsted, Eva Rabing Brix Petersen, Tomasz Pielak, Maj Britt Fruekilde, Jesper Eugen-Olsen
Publikováno v:
Skovsted, T A, Petersen, E R B, Fruekilde, M-B, Pedersen, A K, Pielak, T & Eugen-Olsen, J 2020, ' Validation of suPAR turbidimetric assay on Cobas® (c502 and c702) and comparison to suPAR ELISA ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 80, no. 4, pp. 327-335 . https://doi.org/10.1080/00365513.2020.1741674
suPAR is a plasma marker of chronic inflammation, and an elevated suPAR is consistently associated with worse outcome in a variety of clinical conditions. Quantification of suPAR is useful for determining patient risk in triage, but there is no fast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdee52e555fd7374d1874558a08c4a2c
https://portal.findresearcher.sdu.dk/da/publications/9840f7bf-2028-40b1-b8b8-0a0287ce963e
https://portal.findresearcher.sdu.dk/da/publications/9840f7bf-2028-40b1-b8b8-0a0287ce963e
Autor:
Signe Rosenlund, Frederik Persson, Tomasz Pielak, Peter Rossing, Jens Faber, Bernt Johan von Scholten, Jesper Eugen-Olsen, Tine W. Hansen
Publikováno v:
Diabetes, Obesity and Metabolism. 19:901-905
We assessed the effects of liraglutide treatment on five cardiovascular risk biomarkers, reflecting different pathophysiology: tumour necrosis factor (TNF)-α; soluble urokinase plasminogen activator receptor (suPAR); mid-regional pro-adrenomedullin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::008e889681487c4be7b979ee7caa59de
https://doi.org/10.1111/dom.12884
https://doi.org/10.1111/dom.12884
Autor:
Habib Samady, Tomasz Pielak, Laurence S. Sperling, Danny J. Eapen, Michel T. Corban, Olivia Y. Hung, Michael C. McDaniel, Girum Mekonnen, Parham Eshtehardi, Bill D. Gogas, Christian W. Thorball, Hatem Al-Kassem, Emad Rasoul-Arzrumly, Arshed A. Quyyumi
Publikováno v:
Atherosclerosis. 239:55-60
Background : Soluble urokinase-type plasminogen activator receptor (suPAR) is a novel biomarker released from leukocytes and endothelial cells that has been associated with atherosclerotic cardiovascular disease. We hypothesized that plasma suPAR lev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8a5287c8066fa77452bb0e9eebf9eb
https://doi.org/10.1016/j.atherosclerosis.2014.12.025
https://doi.org/10.1016/j.atherosclerosis.2014.12.025
Autor:
Danny J. Eapen, Salim S. Hayek, Nima Ghasemzadeh, Emir Veledar, Stephen E. Epstein, Pankaj Manocha, Yi-An Ko, A. Maziar Zafari, Tomasz Pielak, Sergey Sikora, Viola Vaccarino, Riyaz S. Patel, Dimitrios Kremastinos, Laurence S. Sperling, Stamatios Lerakis, Arshed A. Quyyumi, Christian W. Thorball, Hatem Al Kassem, Mohamed Khayata
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 10
Background— Inflammation, coagulation, and cell stress contribute to atherosclerosis and its adverse events. A biomarker risk score (BRS) based on the circulating levels of biomarkers C-reactive protein, fibrin degradation products, and heat shock
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95794927be66825a93bda433762e613c
https://doi.org/10.1161/circoutcomes.115.001493
https://doi.org/10.1161/circoutcomes.115.001493